Here’s Who Just Picked Up Photomedex Inc (NASDAQ:PHMD) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Photomedex Inc (NASDAQ:PHMD) reported that Pell Lewis C has picked up 424,064 of common stock as of 2017-05-01.
The acquisition brings the aggregate amount owned by Pell Lewis C to a total of 424,064 representing less than 9.7% stake in the company.
For those not familiar with the company, PhotoMedex, Inc. is a global health products and services company providing integrated disease management and solutions to dermatologists, professional aestheticians and consumers. The Company provides products and services that address skin diseases and conditions, including acne and photo damage. The Company operates through three business segments: Consumer segment, Physician Recurring segment and Professional segment. The Company provides skin health solutions to spa markets, as well as traditional retail, online and infomercial outlets for home-use products. The Company’s Consumer segment is engaged in the designing, development, manufacturing and selling of long-term hair reduction and acne consumer products. Its Physician Recurring segment is engaged in the sales of skincare products. Its Professional segment is engaged in the sale of equipment, such as medical and esthetic light and heat based products. Its LHE brands includes Mistral, Kona, FSD, SpaTouch Elite and accessories.
A glance at Photomedex Inc (NASDAQ:PHMD)’s key stats reveals a current market capitalization of 5.27 Million based on 4.36 Million shares outstanding and a price at last close of $1.26 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2012-06-14, Melumad picked up 1,000 at a purchase price of $10.57. This brings their total holding to 8,000 as of the date of the filing.
On the sell side, the most recent transaction saw Connelly unload 1,704 shares at a sale price of $2.61. This brings their total holding to 1,435.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Photomedex Inc (NASDAQ:PHMD) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
International Isotopes Inc. (OTCBB:INIS) is Attracting Smart Money
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), International Isotopes Inc. (OTCBB:INIS) reported that Kennerman Associates, Inc. has picked up 195,304,771 of common stock as of 2017-05-01.
The acquisition brings the aggregate amount owned by Kennerman Associates, Inc. to a total of 195,304,771 representing less than 43.3% stake in the company.
For those not familiar with the company, International Isotopes Inc. is a manufacturer of nuclear medicine calibration and reference standards, a range of products, including cobalt teletherapy sources, and a selection of radioisotopes and radiochemicals for medical research and clinical devices. Its segments include Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, Fluorine Products, Radiological Services and Transportation. The Nuclear Medicine Standards segment manufactures sources and standards associated with Single Photon Emission Computed Tomography (SPECT) imaging, patient positioning and calibration or operational testing of dose measuring equipment for the nuclear pharmacy industry. Cobalt Products include the production of bulk cobalt (cobalt-60), fabrication of cobalt capsules for radiation therapy or various industrial applications, and recycling of expended cobalt sources. Radiochemical Products include production and distribution of various isotopically pure radiochemicals.
A glance at International Isotopes Inc. (OTCBB:INIS)’s key stats reveals a current market capitalization of 28.49 Million based on 406.96 Million shares outstanding and a price at last close of $0.07 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2015-03-06, Grosso picked up 1,766,667 at a purchase price of $0.02. This brings their total holding to 19,845,926 as of the date of the filing.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on International Isotopes Inc. (OTCBB:INIS) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Baird Brent D Picked Rand Logistics Inc. (NASDAQ:RLOG) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Rand Logistics Inc. (NASDAQ:RLOG) reported that Baird Brent D has picked up 1,600,000 of common stock as of 2017-05-01.
The acquisition brings the aggregate amount owned by Baird Brent D to a total of 1,600,000 representing less than 8.59% stake in the company.
For those not familiar with the company, Rand Logistics, Inc. is a shipping company that, through its operating subsidiaries, is engaged in the operation of bulk carriers on the Great Lakes. The Company’s shipping business is operated in Canada by Lower Lakes Towing Ltd. (Lower Lakes Towing) and in the United States by Lower Lakes Transportation Company (Lower Lakes Transportation). The Company transports construction aggregates, salt, grain, coal, iron ore, and other dry bulk commodities for customers in the construction, electric utility, food, and integrated steel industries. Lower Lakes’ fleet consists of approximately six self-unloading bulk carriers and over four conventional bulk carriers in Canada and approximately six self-unloading bulk carriers in the United States, including over three articulated tug and barge units. Lower Lakes Towing owns approximately nine Canadian vessels and Lower Lakes Towing (17) Ltd. (Lower Lakes (17)) owns the tenth Canadian vessel.
A glance at Rand Logistics Inc. (NASDAQ:RLOG)’s key stats reveals a current market capitalization of 13.62 Million based on 18.62 Million shares outstanding and a price at last close of $0.720 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-03-11, Levy picked up 1,500 at a purchase price of $1.04. This brings their total holding to 470,674 as of the date of the filing.
On the sell side, the most recent transaction saw Knott unload 18,013 shares at a sale price of 0.86. This brings their total holding to 260,135.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Rand Logistics Inc. (NASDAQ:RLOG) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Guess Who Picked Onconova Therapeutics Inc. (NASDAQ:ONTX) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Onconova Therapeutics Inc. (NASDAQ:ONTX) reported that Sabby Capital has picked up 702,896 of common stock as of 2017-05-01.
The acquisition brings the aggregate amount owned by Sabby Capital to a total of 702,896 representing less than 7.61% stake in the company.
For those not familiar with the company, Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company operates through the identification and development of oncology therapeutics segment. It is focused on discovering and developing small molecule drug candidates to treat cancer. The Company has created a targeted anti-cancer agents designed to work against specific cellular pathways that are important to cancer cells. It has over three clinical-stage product candidates and various preclinical programs that target kinases, cellular metabolism or cell division in preclinical development. The Company’s lead product candidate, rigosertib, is being tested in both intravenous (IV) and oral formulations as a single agent, and the oral formulation is also being tested in combination with azacitidine, in clinical trials for patients with myelodysplastic syndromes (MDS), and related cancers. Its other product candidates include Briciclib and Recilisib.
A glance at Onconova Therapeutics Inc. (NASDAQ:ONTX) key stats reveals a current market capitalization of 22.72 Million based on 9.24 Million shares outstanding and a price at last close of $2.35 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2017-04-26, Bienen picked up 3,810 at a purchase price of $2.10. This brings their total holding to 12,724 as of the date of the filing.
On the sell side, the most recent transaction saw Kumar unload 20,000 shares at a sale price of 15.11. This brings their total holding to 276,500.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Onconova Therapeutics Inc. (NASDAQ:ONTX) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Here’s Who Just Picked Up TrueCar Inc. (NASDAQ:TRUE) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), TrueCar Inc. (NASDAQ:TRUE) reported that Caledonia (private) Investments Pty Ltd has picked up 8,651,911 of common stock as of 2017-05-01.
The acquisition brings the aggregate amount owned by Caledonia (private) Investments Pty Ltd to a total of 8,651,911 representing less than 9.93% stake in the company.
For those not familiar with the company, TrueCar, Inc. is an Internet-based information, technology, and communication services company. The Company has a data-driven online platform, which features market data and analytics. The Company-branded platform is available on its TrueCar Website and mobile applications. It customizes and operates its platform on a co-branded basis for its affinity group marketing partners, including financial institutions, membership-based organizations, and employee buying programs for a range of enterprises. The Company enables users to obtain market-based pricing data on new and used cars, and to connect with its network of TrueCar Certified Dealers. Its network of over 13,000 TrueCar Certified Dealers consists primarily of new car franchises, as well as independent dealers selling used vehicles. Its subsidiary, ALG, Inc., provides forecasts and consulting services regarding determination of the residual value of an automobile at given future points in time.
A glance at TrueCar Inc. (NASDAQ:TRUE)’s key stats reveals a current market capitalization of 1.57 Billion based on 89.10 Million shares outstanding and a price at last close of $17.72 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-03-09, Claus picked up 5,000 at a purchase price of $5.70. This brings their total holding to 80,000 as of the date of the filing.
On the sell side, the most recent transaction saw Gunsagar unload 25,571 shares at a sale price of $14.70. This brings their total holding to 315,181.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on TrueCar Inc. (NASDAQ:TRUE) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.